Since the discovery of long-term potentiation (LTP) about a half-century ago, Ca 2+ /CaM-dependent protein kinase II (CaMKII) has been one of the most extensively studied components of the molecular machinery that regulate plasticity. This unique dodecameric kinase complex plays pivotal roles in LTP by phosphorylating substrates through elaborate regulatory mechanisms, and is known to be both necessary and sufficient for LTP. In addition to acting as a kinase, CaMKII has been postulated to have structural roles because of its extraordinary abundance and diverse interacting partners. It now is becoming clear that these two functions of CaMKII cooperate closely for the induction of both functional and structural synaptic plasticity of dendritic spines. Keywords: CaMKII, cytoskeleton, synaptic plasticity. This article is part of a mini review series: "Synaptic Function and Dysfunction in Brain Diseases".CaMKII is a serine (S)/threonine (T)-specific protein kinase activated by the Ca 2+ /calmodulin (CaM) complex, consisting of catalytic, regulatory (autoinhibitory/CaM binding) and association domains. Under basal conditions, CaMKII is subject to autoinhibition via an interaction between its kinase and regulatory domains in the absence of Ca 2+ /CaM. In this 'closed' conformation, a pseudosubstrate segment and T286 in the regulatory domain bind to the S (substrate binding) site and T (T286 binding) site in the catalytic domain, respectively, thus preventing the access of substrates. A recent structural study demonstrated that the compact arrangement of inactive CaMKII holoenzyme renders the CaM-binding domain inaccessible, and the strength of the autoinhibitory interaction (degree of 'compactness') depends on the length of linker between the kinase and association domain (Chao et al. 2011). Abbreviations used: AMPA, a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; CaM, calmodulin; CaMKII, Ca 2+ /calmodulin-dependent protein kinase II; FRET, F€ orster resonance energy transfer; GAP, GTPase-activating protein; GEF, guanine nucleotide exchange factor; GluA1/2, AMPA-type glutamate receptor subunits 1 and 2; GluN1, 2A and 2B, NMDA-type glutamate receptor subunits 1, 2A and 2B; GTPase, guanosine triphosphatase; PDZ, Post synaptic density protein (PSD95), Drosophila disc large tumor suppressor (Dlg1), and Zonula occludens-1 protein (Zo-1); KIF17, kinesin-like protein 17; LTD, long-term depression; LTP, long-term potentiation; NMDA, N-methyl-D-aspartate; SAP97, synapse-associated protein 97; SynGAP, synaptic GTPaseactivating protein.